Biogen hires Jane Grogan as head of research
Grogan joins Biogen following a decades-long career in biopharma, including leadership roles at Genentech and Graphite Bio.
Stay updated with breaking news from Graphite Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Grogan joins Biogen following a decades-long career in biopharma, including leadership roles at Genentech and Graphite Bio.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Graphite Bio, Inc. (NASDAQ:GRPH – Get Free Report) saw a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 990,500 shares, a decrease of 13.1% from the July 31st total of 1,140,000 shares. Based on an average daily trading volume, of 151,000 shares, the days-to-cover […]
03.08.2023 - Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today reported financial results for the second quarter ended ...
Graphite Bio, Inc. (NASDAQ:GRPH – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for shares of Graphite Bio in a note issued to investors on Tuesday, July 11th. Cantor Fitzgerald analyst O. Brayer anticipates that the company will post earnings of ($0.61) per share for the year. […]